These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 16438160

  • 1. Von Willebrand factor (vWF) antigen levels and function in healthy Thais.
    Rojnuckarin P, Akkawat B, Intragumtornchai T.
    Southeast Asian J Trop Med Public Health; 2005 Sep; 36(5):1292-7. PubMed ID: 16438160
    [Abstract] [Full Text] [Related]

  • 2. [Application of collagen-binding assay for von Willebrand disease].
    Zhou J, Jia YQ, Jiang H, Yang YM, Deng CQ.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Jan; 35(1):126-9. PubMed ID: 14981837
    [Abstract] [Full Text] [Related]

  • 3. Development of a collagen-binding activity assay as a screening test for type II von Willebrand disease in dogs.
    Sabino EP, Erb HN, Catalfamo JL.
    Am J Vet Res; 2006 Feb; 67(2):242-9. PubMed ID: 16454628
    [Abstract] [Full Text] [Related]

  • 4. Platelet von Willebrand factor determination does not improve the diagnosis of patients with suspected Type 1 von Willebrand disease.
    Shihong I, Morris D, Konkle BA.
    Haemophilia; 2009 Jan; 15(1):131-4. PubMed ID: 18976254
    [Abstract] [Full Text] [Related]

  • 5. Characterization of recessive severe type 1 and 3 von Willebrand Disease (VWD), asymptomatic heterozygous carriers versus bloodgroup O-related von Willebrand factor deficiency, and dominant type 1 VWD.
    Michiels JJ, Berneman Z, Gadisseur A, van der Planken M, Schroyens W, van de Velde A, van Vliet H.
    Clin Appl Thromb Hemost; 2006 Jul; 12(3):277-95. PubMed ID: 16959681
    [Abstract] [Full Text] [Related]

  • 6. Effect of ABO blood group on the collagen-binding assay for von Willebrand factor.
    Haley E, Babar N, Ritter C, Downes KA, Green D, Shurin S, Sarode R.
    Am J Hematol; 2002 Nov; 71(3):229-31. PubMed ID: 12410584
    [Abstract] [Full Text] [Related]

  • 7. Reassessment of ABO blood group, sex, and age on laboratory parameters used to diagnose von Willebrand disorder: potential influence on the diagnosis vs the potential association with risk of thrombosis.
    Favaloro EJ, Soltani S, McDonald J, Grezchnik E, Easton L, Favaloro JW.
    Am J Clin Pathol; 2005 Dec; 124(6):910-7. PubMed ID: 16416741
    [Abstract] [Full Text] [Related]

  • 8. ABO blood group genotypes, plasma von Willebrand factor levels and loading of von Willebrand factor with A and B antigens.
    Morelli VM, de Visser MC, van Tilburg NH, Vos HL, Eikenboom JC, Rosendaal FR, Bertina RM.
    Thromb Haemost; 2007 Apr; 97(4):534-41. PubMed ID: 17393014
    [Abstract] [Full Text] [Related]

  • 9. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
    Gadisseur A, Berneman Z, Schroyens W, Michiels JJ.
    Acta Haematol; 2009 Apr; 121(2-3):128-38. PubMed ID: 19506359
    [Abstract] [Full Text] [Related]

  • 10. Content and functional activity of von Willebrand factor in apheresis plasma.
    Burnouf T, Caron C, Burkhardt T, Goudemand J.
    Vox Sang; 2004 Jul; 87(1):27-33. PubMed ID: 15260819
    [Abstract] [Full Text] [Related]

  • 11. Cold storage of citrated whole blood induces drastic time-dependent losses in factor VIII and von Willebrand factor: potential for misdiagnosis of haemophilia and von Willebrand disease.
    Böhm M, Täschner S, Kretzschmar E, Gerlach R, Favaloro EJ, Scharrer I.
    Blood Coagul Fibrinolysis; 2006 Jan; 17(1):39-45. PubMed ID: 16607078
    [Abstract] [Full Text] [Related]

  • 12. Laboratory diagnosis and molecular basis of mild von Willebrand disease type 1.
    Michiels JJ, Berneman Z, Gadisseur A, van der Planken M, Schroyens W, van Vliet HH.
    Acta Haematol; 2009 Jan; 121(2-3):85-97. PubMed ID: 19506353
    [Abstract] [Full Text] [Related]

  • 13. Comparison of the pharmacokinetics of two von Willebrand factor concentrates [Biostate and AHF (High Purity)] in people with von Willebrand disorder. A randomised cross-over, multi-centre study.
    Favaloro EJ, Lloyd J, Rowell J, Baker R, Rickard K, Kershaw G, Street A, Scarff K, Barrese G, Maher D, McLachlan AJ.
    Thromb Haemost; 2007 Jun; 97(6):922-30. PubMed ID: 17549293
    [Abstract] [Full Text] [Related]

  • 14. Laboratory diagnosis and molecular classification of von Willebrand disease.
    Gadisseur A, Hermans C, Berneman Z, Schroyens W, Deckmyn H, Michiels JJ.
    Acta Haematol; 2009 Jun; 121(2-3):71-84. PubMed ID: 19506352
    [Abstract] [Full Text] [Related]

  • 15. Distribution of von Willebrand factor levels in young women with and without bleeding symptoms: influence of ABO blood group and promoter haplotypes.
    Lethagen S, Hillarp A, Ekholm C, Mattson E, Halldén C, Friberg B.
    Thromb Haemost; 2008 Jun; 99(6):1013-8. PubMed ID: 18521502
    [Abstract] [Full Text] [Related]

  • 16. von Willebrand factor binding to collagen in patients with end-stage renal disease.
    Niesvizky R, Calandri C, Patel ND, Zhou SL, Potter BJ, Rand JH.
    J Lab Clin Med; 1994 Jan; 123(1):137-42. PubMed ID: 8288954
    [Abstract] [Full Text] [Related]

  • 17. Desmopressin therapy to assist the functional identification and characterisation of von Willebrand disease: differential utility from combining two (VWF:CB and VWF:RCo) von Willebrand factor activity assays?
    Favaloro EJ, Thom J, Patterson D, Just S, Dixon T, Koutts J, Baccala M, Rowell J, Baker R.
    Thromb Res; 2009 Apr; 123(6):862-8. PubMed ID: 19064279
    [Abstract] [Full Text] [Related]

  • 18. Laboratory diagnosis and monitoring of desmopressin treatment of von Willebrand's disease by flow cytometry.
    Giannini S, Mezzasoma AM, Leone M, Gresele P.
    Haematologica; 2007 Dec; 92(12):1647-54. PubMed ID: 18055988
    [Abstract] [Full Text] [Related]

  • 19. Von Willebrand factor in Italian centenarians.
    Coppola R, Mari D, Lattuada A, Franceschi C.
    Haematologica; 2003 Jan; 88(1):39-43. PubMed ID: 12551825
    [Abstract] [Full Text] [Related]

  • 20. Measurement of von Willebrand factor binding to a recombinant fragment of glycoprotein Ibalpha in an enzyme-linked immunosorbent assay-based method: performances in patients with type 2B von Willebrand disease.
    Caron C, Hilbert L, Vanhoorelbeke K, Deckmyn H, Goudemand J, Mazurier C.
    Br J Haematol; 2006 Jun; 133(6):655-63. PubMed ID: 16704443
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.